OXYTOCIN Research Guide | Standard Labs

Overview

The “bonding hormone.” Released during touch, intimacy, and childbirth; it promotes trust, connection, and calm.

Used (usually as a nasal spray) for social/mood support and intimacy.

What It Does

Oxytocin is a 9-amino-acid neurohormone acting on oxytocin receptors in the brain and periphery.

Centrally it modulates social bonding, trust, stress buffering, and mood; peripherally it affects uterine and lactation physiology.

Intranasal delivery targets central effects; SubQ also used.

Peak CNS effect ~30–45 min after intranasal dosing.

Reconstitution

Vial Size	BAC Water / Solvent	Concentration
2 mg	+ 1 mL	2 mg/mL (~1000 IU/mL)
10 mg	+ 5 mL	2 mg/mL (~1000 IU/mL)

Interactive tool

Reconstitution Calculator

Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.

Vial amount

Diluent volume

Calculated concentration—Enter both values above.

Optional conversion

Enter a target amount you already have and select the syringe capacity.

Target amount

Syringe capacity

Calculated draw—Enter concentration inputs and a target amount.

Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.

Protocol

Phase	Frequency	Amount	Notes
Intranasal	As needed or 1–2×/day	24–40 IU (~3 sprays/nostril at ~4 IU each)
SubQ	As needed	5–10 IU (~50–100 mcg)

Cycle & Timing

use as-needed, or 24 IU twice daily for 4–12 weeks in chronic-dosing protocols.

Timing

~30–45 min before the desired social/intimacy effect (intranasal). Note: short-acting; effects are situational, not cumulative.

Population Considerations

Bonding and intimacy in both sexes; in women, sensitivity can shift with estrogen across the cycle.

Handling & Stacking

Injection site

Intranasal spray (primary) or SubQ abdomen.

Storage

Freeze-dried: -4°F.
Reconstituted: 36–46°F; nasal bottle best used within ~2–4 weeks (this is the one compound here with real published stability data); keep it cold and dark.
Protect from light.

Side effects

Usually mild, nasal irritation, headache, mood shifts. Higher/frequent doses can blunt receptors or cause emotional flattening.

What to expect

Situational increase in warmth, trust, calm, and intimacy.
Effects are short-lived and context-dependent.
Supply math 2mg → 3 vials | 10mg → 1 vial (8-wk @ ~24 IU 2/day; far less if as needed)

Pairs well with

PT-141 (intimacy); Kisspeptin (libido/hormonal); Selank (anxiolytic)

Avoid

Pregnancy (uterotonic). Hyponatremia / excessive water intake (antidiuretic effect at high doses). Overuse (receptor blunting)

Safety & Patient Education

Contraindications

Pregnancy (uterotonic, can trigger contractions) Hyponatremia or conditions of water overload Hypersensitivity to oxytocin

Warnings

Antidiuretic (vasopressin-like) effect at high doses, water retention / hyponatremia risk Receptor blunting / emotional flattening with frequent high dosing Can intensify or distort emotional responses, situational Cardiovascular effects (BP/heart rate) at high doses

Drug interactions

Vasoconstrictors / some migraine drugs: additive cardiovascular effects Excess fluids: compounds hyponatremia risk

Labs

Sodium if using high/frequent doses Generally none for occasional intranasal use Out of range? Low sodium = too much / too frequent dosing → ease off.

Stop criteria

Headache, confusion, nausea (possible hyponatremia) Emotional flattening or worsened mood Any uterine cramping (if applicable)

Patient education

Short-acting and situational, not a daily mood drug for most Don’t over-dose; more can blunt the effect and flatten emotion Avoid in pregnancy Don’t combine high doses with excessive water intake

References

researchdosing · peptidedosages · PubMed · thepeptidereport · Oxytocin sex differences